These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 11939870)

  • 21. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
    Bridge JA; Birmaher B; Iyengar S; Barbe RP; Brent DA
    Am J Psychiatry; 2009 Jan; 166(1):42-9. PubMed ID: 19047322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of placebo rates in major depressive disorder trials.
    Stolk P; Ten Berg MJ; Hemels ME; Einarson TR
    Ann Pharmacother; 2003 Dec; 37(12):1891-9. PubMed ID: 14632596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.
    Furukawa TA; Cipriani A; Atkinson LZ; Leucht S; Ogawa Y; Takeshima N; Hayasaka Y; Chaimani A; Salanti G
    Lancet Psychiatry; 2016 Nov; 3(11):1059-1066. PubMed ID: 27726982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for managing sexual dysfunction induced by antidepressant medication.
    Taylor MJ; Rudkin L; Bullemor-Day P; Lubin J; Chukwujekwu C; Hawton K
    Cochrane Database Syst Rev; 2013 May; (5):CD003382. PubMed ID: 23728643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of demographic factors on the antidepressant effect: A patient-level data analysis from depression trials submitted to the Pharmaceuticals and Medical Devices Agency in Japan.
    Nakabayashi T; Hara A; Minami H
    J Psychiatr Res; 2018 Mar; 98():116-123. PubMed ID: 29334636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, prospective pilot study of patient expectancy and antidepressant outcome.
    Rutherford BR; Marcus SM; Wang P; Sneed JR; Pelton G; Devanand D; Duan N; Roose SP
    Psychol Med; 2013 May; 43(5):975-82. PubMed ID: 22971472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
    Loder E; Goldstein R; Biondi D
    Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
    Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
    Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
    Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI
    J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder.
    Cameron IM; Reid IC; MacGillivray SA
    J Affect Disord; 2014 Sep; 166():48-58. PubMed ID: 25012410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z; Gonda X
    J Affect Disord; 2008 Jun; 108(3):195-8. PubMed ID: 18280581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuation and maintenance treatments for depression in older people.
    Wilkinson P; Izmeth Z
    Cochrane Database Syst Rev; 2012 Nov; 11():CD006727. PubMed ID: 23152240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.